org placeholder image

Mike Kelly

Senior Vice President Cmc at Atsena Therapeutics

  • LinkedIn

Email Email: m****@atsenatx.com

phone noPhone Number: (***)-***-****

map
ATSENA THERAPEUTICS

ATSENA THERAPEUTICS

  • description Description
    Atsena Therapeutics is a clinical-stage gene therapy company developing novel treatments for inherited forms of blindness. The company has two clinical-stage programs, ATSN-201 for X-linked r...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 1 Million to 5 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Atsena Therapeutics Org Chart and Mapping

Employees

Mike Kelly

Senior Vice President Cmc

Laura Pardon

Senior Clinical Scientist

Eva Andres-Mateos

Vice President of Translational Research

Christine Kay

Clinical Ophthalmology Advisor

Elisabeth Leiderman

Chief Financial Officer & Chief Business Officer

Tess Handy

Senior Research Associate

Benjamin Fenton

Senior Scientist II, Translational Sciences

Frequently Asked Questions Regarding Mike Kelly

Answer: Mike Kelly works for Atsena Therapeutics as Senior Vice President Cmc

Answer: Mike Kelly’s role in Atsena Therapeutics is Senior Vice President Cmc

Answer: Mike Kelly's email address is m***@gmail.com

Answer: Mike Kelly's business email address is m****@atsenatx.com

Answer: Mike Kelly’s direct phone number is (***)-***-****

Answer: Mike Kelly works in the industry of: Biotechnology

Answer: Mike Kelly works Atsena Therapeutics located at 5 Laboratory Dr, Durham, North Carolina, 27709, United States

Answer: Atsena Therapeutics's Senior Vice President Cmc is Mike Kelly

Answer: Mike Kelly contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@atsenatx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access